CMS: Moving From Pay For Quantity Towards Pay For Performance

On October 1, 2012, the Centers for Medicare and Medicaid Services (CMS) implemented two long-anticipated programs under the Affordable Care Act of 2010 (ACA): the Hospital Value-Based Purchasing Program (VBP), and the Hospital Readmissions Reduction Program (RRP). 

Hospital Value-Based Purchasing Program

The VBP was initiated by CMS to reward “acute-care hospitals with incentive payments for the quality of care they provide to people with Medicare.”  The program applies to all hospitals, except psychiatric hospitals, rehabilitation hospitals, children’s hospitals, long term care hospitals, and certain cancer and research facilities. The program also excludes hospitals subject to payment reductions under Hospital IQR; hospitals cited for deficiencies during the performance period that pose immediate jeopardy to the health or safety of patients; and hospitals that do not meet minimum requirements of cases, measures, or surveys during the performance period. The program will pay incentives based upon a score weighted 70% on the quality of performance, measured by a set of standard clinical quality measurements (Clinical Process of Care measurements), and 30% on patient experience surveys (Patient Experience of Care dimensions). The hospital’s score will be measured against either achievement or improvement, whichever is higher. The “achievement” calculation measures a hospital against all other hospitals’ baseline period performance scores, while the “improvement” score measures a hospital’s current score against its own baseline period performance score.  Under this program, patient experience is a key component of a hospital’s score, so establishing action plans that will maximize patient experience should be a focus for hospitals wishing to maximize incentive payments under the program.

As of October 1, 2012 (the start of the 2013 Federal fiscal year), hospitals will begin to receive payments under the program based on their performance during the period from July 1, 2011, to March 31, 2012.   Hospitals participating in VBP will have their base operating DRG payments for each patient discharge reduced by a percentage each year, beginning with a 1% reduction for the 2013 fiscal year. However, under VBP, a hospital that meets the performance standards set by CMS will recover a portion of the withheld payments through receipt of the incentive payments, and can even receive funds in excess of the reduction depending on the amount of incentives received.

It is too early to tell what effect the VBP program will have on a hospital’s bottom line, and studies indicate that the program may have little effect at all, but hospitals should pay attention to the guidelines as other commercial reimbursement models may be moving towards this system.  Hospitals with an active MyQualityNet account can review their 2013 Estimated Percentage Payment Summary Report at http://www.qualitynet.org.

Hospital Readmissions Reduction Program

RRP requires CMS to reduce payments to hospitals with excessive readmissions following discharge. Under this program, CMS will withhold up to 1% of a hospital’s base operating DRG payments. The program penalizes hospitals whose rates of Medicare readmissions within thirty days of discharge are higher than the national averages. This program will apply to three measures in the 2013 Federal fiscal year (heart attack, heart failure, and pneumonia) and will expand to include COPD, CABG, PTCA, and certain other vascular conditions in the 2015 Federal fiscal year.

RRP has the potential to impose stiff penalties on hospitals.  The government has announced that two-thirds of the hospitals serving Medicare patients - approximately 2,200 facilities - will be assessed penalties averaging around $125,000 per facility this coming year. The penalties under the program will rise to 3% by 2015.

Hospitals are often helpless to control what happens when a patient leaves the hospital.  To avoid penalties under this program, hospitals will need to increase their focus on discharge planning and work closely with other health care and social service providers to ensure appropriate follow-up care for the patient once they leave the hospital.

Shaking Up Pharmaceutical Marketing to Physicians: $3Billion Settlement Imposed Standards and Transparency Far Beyond Sunshine Act

sunsetWhile the headlines reported colorful allegations of kickbacks to physicians, such as Hawaiian vacations and Madonna tickets, and the stunning magnitude of the largest healthcare fraud settlement and payment by a drug company , the most significant aspect of the $3 Billion settlement by global pharmaceutical giant GlaxoSmithKline LLC (GSK) was the Corporate Integrity Agreement  (CIA), which restructures its sales and promotion practices.  The alleged misconduct involved “off-label” drug promotions (recommendations to use medicines for different conditions and patients than the FDA approved), payment of kickbacks, making false and misleading statements concerning the safety of Avandia, and reporting false “best prices” in order to underpay rebates owed under the Medicaid Drug Rebate Program.

With the theme “patients before profits, science before sales” the government set about to restructure GSK’s marketing practices in significant ways.  In addition to changing its incentive compensation practices, such that executive bonuses are now required to be clawed back for regulatory compliance failures, and field representative compensation must be based on service quality rather than sales volume, the 123-page CIA outlines a major overhaul of GSK’s physician arrangements policies and procedures.

Physicians and hospitals/academic medical centers may obtain remuneration from drug companies under any number of arrangements, including consulting agreements, speaker programs, service on advisory boards, research, publication activities, and grants for medical education activities.  Concern that these payments may undermine medical judgment or scientific independence led Congress to adopt the “Physician Payments Sunshine Act” reporting requirements, which go into effect on  January 1, 2013.  CMS blogged that the final rule will come later this year.  In the meantime, however, the CIA goes far beyond requiring the transparency of monetary payments. It requires that each type of physician relationship involving compensation be conducted in such a manner as to promote compliance with federal standards.

Physicians should see the following changes, among others, in their relationships with GSK and possibly with other companies that read the CIA as “a word to the wise” and adopt similar compliance practices voluntarily:

  • Physicians will receive a letter from GSK describing the allegations, the settlement, and requesting that physicians report inappropriate promotion of products or other questionable conduct;
  • Any requests by physicians for information on “off-label” uses of drugs will be required to be put in writing, confirming what information was requested, whether or not the request was unsolicited, signed by the medical professional, referred to the Medical Affairs Department, and all such requests for information will be tracked internally at GSK;
  • Drug company sales and field reps may be accompanied by monitors who will observe their meetings with health care providers and assess the promotional materials distributed;
  • Speakers at programs will be required to have compliance training and written agreements describing the scope of the work, speaker fees to be paid (fair market value with annual caps), compliance obligations. In addition, their programs will be monitored and their fees reported on the GSX website;
  • Samples, coupons, and vouchers for drugs will be distributed only to the medical specialty or types of clinical practices for which the drug’s use has been approved;
  • Researchers will have written agreements describing the scope of clinical research or other work, fees based on a pre-set rate structure, and compliance obligations;
  • Physicians who sit on drug formulary boards or who develop clinical guidelines will be required to disclose their financial relationships with GSK; and
  • Sponsorship or funding of grants to healthcare-related organizations in support of educational programs will be limited. The programs must be non-promotional and accurate in nature, and financial relationships with teaching faculty will be disclosed,.

It is important that the health care provider community as well as drug and medical device manufacturers read this CIA in order to have a clear understanding of what the Office of the Inspector General and the FDA expect.  Both business practices and compliance programs may need to be modified or enhanced to address financial incentives related to promotional and scientific activities that could compromise high quality patient care.  Transparency of financial arrangements is useful to raise the question of whether benefits have influenced physician judgment, but this CIA seeks to reform the underlying industry marketing, research, and compensation practices that drive many manufacturers’ arrangements with physicians.

New York State Releases Proposed Regulations to Limit Executive Compensation and Administrative Costs of State-Funded Service Providers

CoinsLast week, 13 New York State agencies, including the Department of Health, released proposed regulations designed to implement the Executive Order issued earlier this year by Governor Andrew Cuomo to limit executive compensation and administrative expenses at service providers that receive State funds or State-authorized payments of federal funds.  The proposed regulations are available for public comment from May 30 until July 16.

In their present form, the proposed regulations apply to providers that receive more than $500,000 and at least 30% of their annual funding from the State.  These limits would include the Federal as well as the State portion of Medicaid payments.  The regulations purport to prevent providers from spending more than $199,000 in State funds for the compensation of an executive. If a provider chooses to pay an executive more than $199,000 from other sources, the provider must keep compensation below the top 25% in the field as determined by a compensation survey identified or recognized by the applicable State agency.  The compensation limit includes cash and noncash benefits, such as wages, bonuses, housing, cars, below-market loans, educational benefits, family travel, and use of an organization’s property.  Mandatory benefits, such as health insurance premiums and pension contributions, are excluded.   

In addition, providers that pay an executive more than $199,000 must have the compensation approved by their boards of directors, including at least two independent directors, and must have performed a review of comparability data.  In cases where competitive imperatives or the complexity of a provider's operations require compensation that exceeds the limits, and in other specified circumstances, providers may apply for a waiver of the compensation limit.

Taking a page from the Affordable Care Act’s limit on health insurers’ overhead expenses, the proposed regulations would also require that at least 75% of a provider's State funds be utilized for program services rather than administrative costs. This percentage will increase by 5% each year until it reaches 85% in 2015.  Capital expenses are not affected by this restriction and waivers would be available in certain circumstances.

The proposed regulations further mandate that providers annually report the public funds they have received, the compensation of their executives and highest-paid employees, and their administrative expenses.  This information would be submitted electronically, using a State-wide form.

Sanctions for non-compliance would include (i) redirection of State funds,  (ii) suspension, limitation, or revocation of the provider’s license to operate/deliver program services, and (iii) suspension, limitation, or revocation of contracts between the State and the provider.

The press release from the Governor’s office, along with a link to the proposed regulations from the Department of Health, can be found here.  We will provide further guidance as these regulations are finalized.

CMS Adds Deadlines to Deem Pharmacy Claims "Clean" Unless Part D Sponsors Timely Contests

Calendar pageCMS tightened the “prompt pay” requirements of the Medicare Improvements for Patients and Providers Act (MIPPA) by the issuance of a final rule, which adds new time frames for objecting to a claim before it is deemed a "clean claim." These requirements, which implement MIPPA's provisions that a claim not contested within the applicable time frames is deemed clean, will be effective 60 days after the final rule is published in the Federal Register on Thursday, September 1, 2011 (on or about October 31, 2011).  Under the new prompt pay requirement, a claim is deemed to be a "clean claim" unless the Part D sponsor notifies the pharmacy of deficiencies or improprieties within 10 calendar days of an electronic claim or point of sale payment, or within 15 calendar days of receipt of a non-electronic claim.  Electronic clean claims must be paid within 14 days and non-electronic clean claims must be paid within 30 days, otherwise, interest must be paid to the pharmacy. 

The new regulation (42 CFR §423.50(c)(2(ii)) adds the following rules for pharmacy claims processing:

  • A claim that is neither paid nor contested within the statutory time frame is deemed a "clean" claim and must be paid in a timely manner (if sponsor snoozes, it looses);
  • Resubmitted claims are deemed "clean" claims if the sponsor does not provide notice to the pharmacy within 10 (electronic claim or point of sale payment) or 15 days (paper claim) of any remaining defects or impropriety; and
  • A sponsor may not contest a resubmitted claim with a new deficiency that could have been identified in the first instance (no second bites at the apple, so the first notice contesting the claim must be complete).

In plain English, Part D sponsors must make sure their initial notice contesting the claim is timely (10 or 15 days), complete, and sufficiently detailed, since new issues cannot be raised to contest resubmitted claims.  Resubmitted claims must also be contested in 10 or 15 days, only with regard to matters relating to the first-identified deficiencies.  For electronic claims or point of sale payments this means that, unless the sponsor sends a notice of deficiencies or remaining deficiencies to the pharmacy within 10 or 15 days of submission or resubmission of a claim, the claim will be deemed "clean" and must be promptly paid.

The new “prompt pay” requirements must be included in CMS contracts with Part D sponsors and in the contracts between sponsors and pharmacies.  A pre-copy of the rule and commentary is available online.

Future HIPAA Audits Coming; Serious Consequences Imposed on Recent Violations; Upgrade for Electronic Health Records.

computer mouseHIPAA audits are coming, but significant HIPAA enforcement is occurring now.  The Office of Civil Rights (OCR) of the U. S. Department of Health and Human Services (HHS) recently awarded  KPMG a $9.2 million contract to conduct HIPAA audits on 150 covered entities and business associates before December 31, 2012.   Booz Allen Hamilton was contracted  to identify HIPAA audit candidates.  An increasing level of enforcement has already been observed (check out “All Signs Point to Ramped-Up HIPAA Enforcement”) and even more enforcement activity is expected as a result of the planned audits. 

The OCR announced its most recent enforcement action on July 7, 2011, a Resolution Agreement and Corrective Action Plan (Plan) with the University of California at Los Angeles Health System to settle violations of the HIPAA Privacy and Security Rules.  OCR found that hospital employees had accessed and reviewed electronic protected health information of celebrity patients repeatedly and without a permissible reason.

The Plan provides for an independent monitor, implementation of updated policies, procedures, and training, but with a significant downside: if the Plan is breached, HHS may impose a civil monetary penalty for the HIPAA breaches.

The takeaway for covered entities and business associates subject to HIPAA is to consider the Plan as a form of “best practices” to use to implement a customized HIPAA compliance program.  It is particularly important for entities to update and actually roll out, train, and enforce their policies and procedures.  Current HIPAA programs are more likely to be based on safeguarding paper medical records and not on properly handling electronic protected health information (PHI) if they have not recently been revised.  In particular, the following concrete steps required by the Plan should be considered for addition to entity HIPAA programs:

  • Update policies and distribute to anyone in the workforce who has access to PHI along with written or electronic compliance certification that the policies have been read and understood, without which employees may not perform services that involve PHI;
  • Policies must address permissible and impermissible use and disclosure of PHI,  information access standards, and sanctions;
  • Train workforce to comply with policies, through updated annual training as appropriate, including written certification that training has been received, without which employees may not have access to PHI;
  • Investigate and respond to non-compliance; and
  • Officer accountability for training and certification of training.

These are practical steps to follow and would serve well in the event of any future HIPAA audit. KPMG has been tasked, in its conduct of HIPAA audits, to visit the entity, interview leadership, examine operations, assess whether policies are being implemented and HIPAA standards are being met, and make recommendations for corrective action going forward.   It is not clear how the OCR will respond to negative audit findings, but it is not sensible to wait for the shoe to drop.  Providers should take a good hard look at their HIPAA privacy and security polices, update them particularly with regard to their current electronic health records operations, then implement them carefully and with appropriate documentation.

First Case Resolved Thru CMS Self-Disclosure

In February of this year, Saints Medical Center became the first health care provider to resolve its Stark violations thru CMS’ new self-disclosure protocol. As a result of the self-disclosure, Saints will make a one-time payment of $579,000 to the government. According to a press release issued by Saints, the matter did not involve quality of care or fraud abuse. Such a statement seems to indicate that the hospital may have disclosed financial arrangements with physicians that were “technically” deficient under Stark (i.e. arrangements were either (i) not in writing or (ii) expired). According to the Lowell Sun, the liability could have gone as high as $14 million.

HospitalStephen J. Guimond, Saints Interim President and Chief Executive Officer, made a point of acknowledging Gov. Patrick, Senators Kerry and Brown, and Rep. Tsongas and thanking them for their support during the settlement negotiations.

For those health care providers thinking of using the new self-disclosure protocol, this outcome is encouraging. CMS’ settlement with Saints seems to indicate that the agency will use its new authority under PPACA to reduce penalties for those who come forward and follow the new self-disclosure protocol guidelines.

AHA Study of Price Differences for U.S. Hospitals

The American Hospital Association (“AHA”) issued its second report in its series examining anti-trust issues in the pricing for hospital services.  The first study rebutted claims made in two widely-cited publications that found links between higher hospital prices to insurers and market power.  The second study examined hospital financial data to determine what factors best explained price differences across hospitals.

The study makes the following points:

  • Hospital expenditures have held steady at approximately 30% of total healthcare expenditures in the U.S. during the period 2001 – 2009.  Home health care expenditures have increased as a share of the total during the same period.  The other categories that have grown faster than hospital care are prescription drugs, program administration and the net cost of private health insurance.
  • Nationwide, Medicare and Medicaid admissions now account for more than 60% of total admissions.  AHA estimates that the Medicare payment-to-cost ratios fell from 99.1% in 2000 to 90.1% in 2009; Medicaid payment-to-cost ratios fell from 94.5% in 2000 to 89% in 2009; and uncompensated care now represents approximately 6% of total hospital expenses.
  • Total hospital admissions grew by 7% between 2000 and 2009, but have been relatively flat since 2004,  due in part to the shift in services to outpatient environments.  Outpatient visits increased 23% between 2000 and 2009.

Using Medicare cost report data from 2004 through 2008, the AHA researchers were able to develop a number of models that they believe explain the price differences across hospitals.  The key explanatory variables are case mix, teaching intensity, share of Medicare and Medicaid discharges, regional costs (wage index), hospital investment in capital, resource utilization and characteristics of the patient population.  One of the models was able to explain 72% of the price variation in commercial payors, and 83% in all payors.

The AHA study explains something we have observed in our practice; that academic medical centers are able to charge payors more for their services.  In the AHA model, the explanation for the higher price difference is due not to the market power of the academic medical center, but the fact that it has a greater teaching intensity, higher wage costs, greater investment in capital and attracts a sicker patient demographic.

Although the researchers were not able to explain all of the price differences, they are able to explain a statistically significant amount.  The AHA study takes issue with the conclusion of some researchers that any residual price variation not captured by the model is due to market power.

Ellis Medicine Announces Cardiac Surgery Warranty Program

Ellis Medicine in Schenectady, New York announced last week that it entered into agreements with MVP Health Care and Capital District Physicians Health Plan to offer a "warranty" to patients who undergo cardiac surgery at its hospital facility.

Under its Cardiac Surgery Warranty program, Ellis has agreed that if a patient following doctor’s orders develops related complications within 90 days of coronary artery bypass graft (CABG) surgery and is readmitted to Ellis, the patient will pay nothing for the second hospital stay. Patients must consent to participate in the Cardiac Surgery Warranty program and sign a contract agreeing to attend rehab, quit smoking and take other steps to reduce the chance of complications. All  the payors' commercial plans are included in the program, including Medicare Advantage plans.

This model is intended to replicate the Proven Care Program at Geisinger Health System in Pennsylvania. The key difference, however, is that the Geisinger system includes both hospitals and payors, whereas Ellis has entered into financial arrangements with two separate and independent entities. Ellis will share with CDPHP and MVP in the responsibility for hospital costs if the patient is readmitted.

Currently, Ellis Medicine’s readmission rates for heart failure patients are no different than the national rate, meaning its rates of readmission are not better or worse than the national average. Geisinger’s rate for readmission for heart failure is better than the national average.

The program includes steps to standardize care before and after surgery. A key legal issue that must be addressed in these arrangements is how the cardiac surgeons will be incentivized to ensure such standardization. Physicians could receive a bonus based on quality measure and other outcomes, but such bonuses must be consistent with fair market value. While data is available to assess the fair market value of a physician’s time, it is not readily available to assess the value of providing quality care.

Medicare Hospital Value-Based Purchasing Program

Qualitychasm.jpgThe Centers for Medicare & Medicaid Services published a proposed rule on January 13, 2011 outlining the proposed Hospital Value-Based Purchasing Program (Hospital VBP Program) mandated by Section 3001(a) of the Patient Protection and Affordable Care Act (PPACA). 

Although the Hospital VBP Program is not effective until October 1, 2012, Medicare hospitals must act now to ensure that they are eligible for incentive payments under the program as the initial performance period begins July 1, 2011.

Background

CMS is required to establish a Hospital VBP Program that provides meaningful incentives to improve the quality of the care that Medicare hospitals provide. The program must be in place by Fiscal Year 2013 (October 1, 2012). The incentive payments are funded by a one percent reduction in hospital DRG payments beginning in Fiscal Year 2013. 

CMS views the Hospital VBP program as a natural outgrowth to the collection of hospital quality data that was originally mandated in the Medicare Prescription Drug Improvement and Modernization Act of 2003, as modified by the Deficit Reduction Act of 2005. This program is known as the Medicare Hospital Inpatient Quality Reporting Program (Hospital IQR Program).

Proposed Measures

PPACA requires that the proposed measures for the Hospital VBP Program be measures that are currently used in the Hospital IQR Program.  CMS has adopted 45 measures in the Hospital IQR program.  Of these measures, 27 are chart-abstracted process of care measures that assess the quality of care furnished by hospitals in connection with treatment of acute myocardial infarction, heart failure, pneumonia, and surgical care improvement.  Fifteen of the measures are claims-based measures that assess the quality of care furnished by hospitals as measured by 30-day mortality and 30-day readmission rates.  Three of the measures are structural measures that assess hospital participation in cardiac surgery, stroke care, and nursing sensitive care systemic databases.   The final measure is the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey. 

CMS may not select readmission measures or any measures that have been included in the Hospital IQR program for less than one year prior to the beginning of the performance period

Applying this criteria, there are twenty-nine initial eligible measures for the Fiscal Year 2013 Hospital VBP Program.  Initially, CMS proposes to include only seventeen of these twenty-nine measures.  It excluded measures that they consider to be “topped out,” meaning all but a few hospitals have achieved a similar high level of performance on them.  They also excluded some measures that they intend to retire in the future.

CMS is proposing to add measures to the Hospital VBP Program in the future by implementing a “sub-regulatory process”.  Under this process, CMS can add any measure to the Hospital VBP Program if that measure is adopted under the Hospital IQR Program and has been included on the Hospital Compare Website for at least one year.  The performance period for new measures would start exactly one year after the date these measures are publicly posted on the Hospital Compare Website.  There is some question whether this sub-regulatory process meets the requirements of the Administrative Procedures Act. 

Proposed Performance Period

CMS is proposing a three quarter performance period from July 1, 2011 through March 31, 2012 for the clinical process of care and HCAHPS measures.  The hospitals performance on these measures will be compared to a three quarter baseline period of July 1, 2009 through March 31, 2010.  For the outcome, claims-based measures, CMS is proposing to use an eighteen month performance period from July 1, 2011 to December 31, 2012.  The baseline period would be July 1, 2008 to December 31, 2009.

Proposed Performance Standards

PPACA requires that the performance standards include levels of achievement and improvement and must be established and announced not later than sixty days prior to the beginning of the performance period. CMS is proposing to set the achievement performance standard for each proposed measure at the median (50th percentile) of hospital performance during the relevant baseline period (either July 1, 2009 through March 31, 2010 or July 1, 2008 to December 31, 2009).  Hospitals would receive achievement points only if they exceed the achievement performance standard and could increase their achievement score if they receive a higher level of performance.  The improvement standard would be based on each specific hospital’s performance on the measure during the performance period as compared to the baseline period.

Expected Impact on Payments

CMS anticipates that the percent increase in payments to a hospital participating in the Hospital VBP Program will range from 0.0236% for the lowest scoring hospital to 1.817% for the highest scoring hospital.  This means that when the one percent reduction in hospital DRG payments is taken into account, roughly one-half of the participating hospitals will receive a net increase of payments and one-half will receive a net decrease in payments.  No participating hospital will receive more than a net one percent increase or decrease in payments.

House Scheduled to Vote on Repeal of PPACA

The U.S. House of Representatives is scheduled to consider and vote on a bill to repeal the Patient Protection and Affordable Care Act (PPACA) next week. The bill is entitled "Repealing the Job-Killing Health Care Law Act." The vote was scheduled to occur this week, but was postponed after the tragedy that occurred in Tucson.

The proposed bill would repeal PPACA in its entirety, even though there are a number of provisions in the law that are popular with the middle class, such as the provision that mandates that plans cover dependents up to the age of 26.  

Congress Again Postpones Medicare Phyisican Fee Cuts

Late last week the House of Representatives passed, with virtually no opposition, legislation that postpones the implementation of the Medicare physician pay cut through the end of 2011. Exactly the same Bill has already been passed by the Senate and should be on President Obama’s desk for signature.

The physician pay cuts would have amounted to 25% as of January 1, 2011 had this Bill not been passed. It is hoped that, with this one year extension, Congress will work out a permanent solution for the physician reimbursement rates.

President Obama is expected to sign the Bill.

 

Congress Once Again Postpones Medicare Physician Reimbursement Rate Cuts

On November 29, 2010, the U.S. House of Representatives passed a bill that had already been passed in mid-November by the U.S. Senate which delays an automatic cut in physician reimbursement rates under Medicare.  The legislation was immediately signed by President Obama.  Without this legislation, December 1, 2010 would have brought a 23% pay cut for physicians in Medicare.  Congress has been postponing the cuts in the physician reimbursement rates since back in 2003.  The combined postponement of cuts over the seven years adds up to a 23% cut today. 

The postponement passed by Congress and just signed into law by President Obama lasts until January 1, 2011.  There are other proposals to postpone the implementation of the cuts for up to another year to enable Congress to deal with a permanent solution.  The physician pay cuts have become a huge political issue for Congress.  Those who favor the postponements argue that if they are put into place, doctors will no longer take Medicare and a number of elderly and disabled people will not have full access to medical care.

Accountable Care Workshop Analysis

The FTC, OIG, and CMS hosted an all-day workshop on Accountable Care Organizations on October 5th. So what did they talk about and what did we learn?

There are a couple of good posts that you should read for a first-hand account.  Beth Graham at Karl Bayer provides a concise summary of the day's events. David Harlow at HealthBlawg also makes some cogent comments and raises the key question on everyone's mind: is this just managed care on steroids?  

Daniel R. Levinson, Inspector General of the Department of Health & Human Services has also made his opening remarks available.

Although I could not attend the workshop, I created a Wordle using the contents of the blog posts and Inspector Levin's remarks. So what are ACOs about: savings and quality. If only words were enough.

Provider Integration Using P4P Programs - Part I

This is the first part of a series on Pay-for-Performance ("P4P") Programs.  A P4P Program should seek to achieve improvement in the quality of patient care through changes in physicians’ clinical or administrative practices. Properly structured, P4P Programs can serve legitimate business and medical purposes by improving efficiency and quality of care. Like any payment arrangement between a hospital and physicians who refer business to the hospital, however, payments purportedly intended to encourage quality improvements might be used by parties to induce reductions in care or to disguise kickbacks for referrals. For those reasons, it is important to build the proper safeguards into any P4P Program.

While tackling compliance issues can sometimes be challenging, the government is encouraging P4P Programs to promote efficiency and quality in our national healthcare system. There are a number of CMS demonstration projects on P4P under way. PPACA requires the Secretary of the Department of Health of Human Services to establish a value-based purchasing program that will affect hospitals by 2013. In addition, CMS proposed a new exception for incentive payments for efficiencies and quality in the 2009 Medicare physician fee schedule. While a final version of the exception has not yet been promulgated, the proposed exception provides useful guidance.

In the next part of this series on P4P Programs, I will discuss some safeguards that can be incorporated into a P4P Program to address key areas of concern from a compliance perspective.

 

Accountable Care Organization Workshop

The Federal Trade Commission, Centers for Medicare & Medicaid Services (CMS), and the Office of the Inspector General will host a workshop on accountable care organizations (ACOs) on October 5, 2010. The workshop will be held at CMS headquarters in Baltimore, MD from 9 am to 4:30 pm.

According to the September 17 notice in the Federal Register, the workshop will include panel discussions on the legal issues related to ACOs, including the antitrust, Stark, and anti-kickback laws.  Interested persons can attend in person or by teleconference.

The first panel will discuss whether independent providers in an ACO should be allowed to engage in joint price negotiations with private payers, and if so, under what circumstances. The second panel will discuss ways to encourage the formation of multiple ACOs in a given geographic market. The third panel will discuss how ACOs will interact with the Stark law, the anti-kickback statute and the civil monetary penalties law. The agencies are also seeking written comments and statements on these topics from the public.

 A key topic of discussion will be whether the Secretary of HHS should use her authority under PPACA to waive the legal requirements that would normally apply to health care providers and whether such waivers should be broad or narrow to accomplish the goal of encouraging the formation of ACOs.